Literature DB >> 24183851

Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.

Yong He1, Xiao-Ming Meng1, Cheng Huang1, Bao-Ming Wu1, Lei Zhang1, Xiong-Wen Lv1, Jun Li2.   

Abstract

Recent advances in non-protein coding part of human genome analysis have discovered extensive transcription of large RNA transcripts that lack of coding protein function, termed long noncoding RNAs (lncRNAs). It is becoming evident that lncRNAs may be an important class of pervasive genes involved in carcinogenesis and metastasis. However, the biological and molecular mechanisms of lncRNAs in diverse diseases are not yet fully understood. Thus, it is anticipated that more efforts should be made to clarify the lncRNAs world. Moreover, accumulating studies have demonstrated that a class of lncRNAs are dysregulated in hepatocellular carcinoma(HCC) and closely related with tumorigenesis, metastasis, prognosis or diagnosis. In this review, we will briefly discuss the regulation and functional role of lncRNAs in HCC, therefore evaluating the potential of lncRNAs as prospective novel therapeutic targets in HCC.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CCKBR; CDH1; CLDN1; CREB; DDIT4; DNA damage-inducible transcript 4; E-cadherin; EZH2; Function; Gtl2; HBx; HCC; HOTAIR; HOXC; HSC; Hepatocellular carcinoma (HCC); IGF2; IGF2 mRNA-binding proteins; IGF2BP; KRT-19; KRT-8; Long noncoding RNAs; MALAT1; MAML1; MEF2C; MEG3; MVIH; P21 associated ncRNA DNA damage activated; PANDA; PGK1; PIWI-interacting RNAs; PRC2; RAB4B; Ras-related GTP-binding protein 4B; SNPs; TERRA; TERT; TSA; Therapeutic targets; Trichostatin A; cAMP responsive element binding protein; cholecystokinin-B receptor; claudin 1; cytokeratin-19; cytokeratin-8; down-regulated expression by hepatitis B virus X protein (HBx); gene trap locus 2; hepatic stellate cells; hepatitis B virus X protein; hepatocellular carcinoma; heterogeneous nuclear ribonucleoprotein K; hnRNP-K; homeobox transcription factors C; hox transcript antisense intergenic RNA; insulin-like growth factor 2; lncRNA High Expression In HCC; lncRNA Low Expression in Tumor; lncRNA-Dreh; lncRNA-HEIH; lncRNA-LET; lncRNAs; lncRNAs associated with microvascular invasion in HCC; long noncoding RNAs; mastermind-like-1; maternally expressed gene 3; metastasis-associated lung adenocarcinoma transcript 1; miRNAs; microRNAs; myocyte-specific enhancer factor 2C; ncRNAs; non-coding RNAs; phospho-glycerate kinase 1; piRNAs; polycomb-repressive complex 2; siRNAs; single nucleotide polymorphisms; small interfering RNAs; telomerase reverse transcriptase; telomeric repeat-containing RNA; zeste homolog 2

Mesh:

Substances:

Year:  2013        PMID: 24183851     DOI: 10.1016/j.canlet.2013.10.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  191 in total

1.  miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.

Authors:  Z Zhao; L Zhang; Q Yao; Z Tao
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

2.  The long non-coding RNA H19 - a new player in hepatocellular carcinoma.

Authors:  Maximilian A Ardelt; Johanna Pachmayr
Journal:  Cell Stress       Date:  2017-10-01

3.  Long non-coding RNAs and hepatocellular carcinoma.

Authors:  Fu-Jun Yu; Jian-Jian Zheng; Pei-Hong Dong; Xiao-Ming Fan
Journal:  Mol Clin Oncol       Date:  2014-09-25

Review 4.  Focusing on long noncoding RNA dysregulation in gastric cancer.

Authors:  Lu Gan; Midie Xu; Yi Zhang; Xia Zhang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-12-13

Review 5.  Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.

Authors:  Chikako Shibata; Motoyuki Otsuka; Takahiro Kishikawa; Motoko Ohno; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Hepatol       Date:  2015-01-27

Review 6.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

7.  UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer.

Authors:  Jun Yin; Wei Luo; Xiang Zeng; Lisi Zeng; Zhiyang Li; Xiaofang Deng; Xiaojun Tan; Weimin Hu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

8.  Upregulation of lncRNA Sox2ot indicates a poor prognosis for patients with hepatocellular carcinoma and promotes cell invasion.

Authors:  Ji Sun; Xiaomou Wei; Li Xu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

9.  Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screening.

Authors:  Ka Yin Lui; Hao-Ran Peng; Jin-Rong Lin; Chun-Hui Qiu; Hu-An Chen; Rong-Dang Fu; Chang-Jie Cai; Min-Qiang Lu
Journal:  Tumour Biol       Date:  2015-08-20

10.  Long noncoding RNA NBAT1 negatively modulates growth and metastasis of osteosarcoma cells through suppression of miR-21.

Authors:  Cheng Yang; Guijiang Wang; Jian Yang; Liguo Wang
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.